Donor Hematopoietic Stem Cell/Lymphocyte Maintenance Treatment After CAR T-Cell Therapy in Patients With B-Cell Acute Lymphoblastic Leukemia Relapse Following Stem Cell Transplant

Maintaining the efficacy of anti-CD19 chimeric antigen receptor modified (CAR) T-cell therapy in patients with B-cell acute lymphoblastic leukemia (B-ALL) relapse after allogeneic hematopoietic stem cell transplant (allo-HSCT) is an urgent problem. In this study, we aimed to compare the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qing, Lyu, Cuicui, Liu, Meijing, Wang, Jia, Mou, Nan, Jiang, Erlie, Zhang, Rongli, Deng, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996720/
https://www.ncbi.nlm.nih.gov/pubmed/36879459
http://dx.doi.org/10.1177/09636897231158155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996720/
https://www.ncbi.nlm.nih.gov/pubmed/36879459
http://dx.doi.org/10.1177/09636897231158155

Ejemplares similares